Sotatercept is the first drug that actually modifies PAH.
MK-0616
Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism
Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol
The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.